Innogenetics Biologicals consists of two units; Process Development Unit and Manufacturing Unit.
The Process Development Unit carries out optimization and scale-up of the fermentation and purification processes and formulation, as well as the method development for in-process controls and for the quality controls of the final drug substance and products.
The production of biologicals under cGMP is performed by the Manufacturing Unit which consists of a manufacturing area, including a formulation and filling area (1540 m2 with extension capacity of 700 m²), offices, warehouse and quality control laboratories (300 m 2) as well as a technical area for HVAC air handling units and utility piping, and for production of water for injection (WFI).